Early Career Special Collection
Early Career special collection, in collaboration with the Society for Endocrinology Early Careers Members
Collection Editors: Kate Lines (University of Oxford, UK), Ruth Casey (Cambridge University Hospital, UK)
Endocrine Oncology is a fully open-access, peer-reviewed journal brought to you by the Society for Endocrinology (SfE) and Bioscientifica, a long-established society publisher.
Endocrine Oncology is proud to support the Early Careers Members of the society by publishing a special collection, guest edited by SfE member, and current Endocrine Oncology Associate Editor, Kate Lines. This collection of research and reviews will showcase the ground breaking work being undertaken by the early careers members across the wide range of endocrine cancer. All articles submitted to this special issue with be subject to full peer review to ensure the quality standard required for publication.
Endocrine Oncology welcomes contributions from the wider SfE early careers community, not just commissioned articles, as well as being open to all the wider endocrine cancer community.
Authors wishing to contribute to this collection, should submit a copy of their abstract, and a copy of their most recent CV to eo@bioscientifica.com for approval by the guest editors.
Eligibility for this particular collection is as follows:
- Scientists: <10 years post PhD with at least 3 publications as first, co-first or as senior author
- Clinical Academics: currently undertaking an MD or PhD or <6 years from completion of MD or PhD with at least 3 publications as first, co-first or as senior author
- Clinicians-in-Practice: up to 12 years from attainment of MBBS with at least 3 publications as first, co-first or as senior author (Clinicians-in-Practice may include Clinical Cases)
This is a great opportunity for early career researches to publish their work in a new launch open-access journal for free, as all Article Processing Charge (APC) fees are currently waived* when publishing in Endocrine Oncology.
Launched at the beginning of 2021, Endocrine Oncology is an open-access, peer-reviewed journal publishing basic, translational and clinical research and reviews on the interplay between hormones and cancer, and related topics.
*Bioscientifica reserves the right to withdraw this offer at any time